1000370-80-8

Basic information

• Product Name: (R)-3-(2-AMino-phenylaMino)-pyrrolidine-1-carboxylic acid tert-butyl ester
• Synonyms: (R)-3-(2-AMino-phenylaMino)-pyrrolidine-1-carboxylic acid tert-butyl ester;(R)-tert-Butyl 3-((2-aMinophenyl)aMino)pyrrolidine-1-carboxylate;(3R)-3-[(2-Aminophenyl)amino]-1-pyrrolidinecarboxylic acid 1,1-dimethylethyl ester
• CAS NO: 1000370-80-8
• Molecular Formula: C15H23N3O2
• Molecular Weight: 277.36202
• Mol File: 1000370-80-8.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (R)-3-(2-AMino-phenylaMino)-pyrrolidine-1-carboxylic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-3-(2-AMino-phenylaMino)-pyrrolidine-1-carboxylic acid tert-butyl ester(1000370-80-8)
• EPA Substance Registry System: (R)-3-(2-AMino-phenylaMino)-pyrrolidine-1-carboxylic acid tert-butyl ester(1000370-80-8)

Safety Data

• Hazardous Substances Data: 1000370-80-8(Hazardous Substances Data)

Usage

General Description

The chemical compound (R)-3-(2-Amino-phenylamino)-pyrrolidine-1-carboxylic acid tert-butyl ester is a derivative of pyrrolidine-1-carboxylic acid with an amino group attached to the phenylamine moiety. It is commonly used in pharmaceutical research and drug development as a potential therapeutic agent. The tert-butyl ester group provides stability and increased solubility, making it easier to work with in laboratory settings. (R)-3-(2-AMino-phenylaMino)-pyrrolidine-1-carboxylic acid tert-butyl ester may have potential applications in the treatment of various medical conditions, but further research and testing are necessary to fully understand its pharmacological properties and potential benefits.

Upstream product

• 1000370-76-2 C₁₅H₂₁N₃O₄ 
• 1493-27-2 ortho-nitrofluorobenzene 
• 147081-49-0 (R)-3-aminopyrrolidine-1-carboxylic acid tert-butyl ester 
• 1000370-76-2 tert-butyl (R)-3-((2-nitrophenyl)amino)pyrrolidine-1-carboxylate 

Relevant articles and documents

(HETERO) ARYL IMIDAZOLONE COMPOUND

PROBLEM TO BE SOLVED: To provide a novel compound that has an inhibitory action on prolyl hydroxylases (PHDs), and is useful as a treatment agent for inflammatory bowel diseases such as ulcerative colitis. SOLUTION: The present disclosure provides a (hetero) aryl imidazolone compound represented by the formula (I) or a pharmacologically acceptable salt thereof (where m, u, p, q and r each denote a specific integer, E, G, Q and T each denote a specific group such as N or CH, W and Z each denote a specific ring, R1 and R3 each denote a specific group such as a halogen atom). SELECTED DRAWING: None COPYRIGHT: (C)2021,JPOandINPIT

New 'chemical probes' to examine the role of the hFPRL1 (or ALXR) receptor in inflammation

We report the development of the novel N-substituted benzimidazole 11 as a potent and selective human formyl peptide receptor-like 1 (hFPRL1) agonist. This compound and its less active enantiomer 12 were identified as useful tools for studying receptor function in vitro.